Stock Analysis
- China
- /
- Medical Equipment
- /
- SZSE:300061
QITIAN Technology Group First Quarter 2024 Earnings: CN¥0.009 loss per share (vs CN¥0.002 profit in 1Q 2023)
QITIAN Technology Group (SZSE:300061) First Quarter 2024 Results
Key Financial Results
- Revenue: CN¥202.3m (down 11% from 1Q 2023).
- Net loss: CN¥5.71m (down by 458% from CN¥1.60m profit in 1Q 2023).
- CN¥0.009 loss per share (down from CN¥0.002 profit in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
QITIAN Technology Group shares are up 4.3% from a week ago.
Risk Analysis
You should learn about the 2 warning signs we've spotted with QITIAN Technology Group (including 1 which shouldn't be ignored).
Valuation is complex, but we're helping make it simple.
Find out whether QITIAN Technology Group is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:300061
QITIAN Technology Group
QITIAN Technology Group Co., Ltd. develops, produces, and sells plastic lenses in China.
Mediocre balance sheet and slightly overvalued.